

House
File
2392
-
Introduced


HOUSE
FILE
2392


BY
COMMITTEE
ON
EDUCATION


(SUCCESSOR
TO
HSB
611)


A
BILL
FOR


An
Act
relating
to
the
administration
of
epinephrine
in
1


schools.
2


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
3


TLSB
6101HV
(1)
85


je/rj



H.F.
2392


Section
1.
Section
280.16,
Code
2014,
is
amended
to
read
as
1


follows:
2


280.16
Self-administration
of
asthma
or
other
airway


3


constricting
disease
medication
certain
medications
.
4


1.
Definitions.
For
purposes
of
this
section
:
5


a.


“Epinephrine
auto-injector”
means
a
medical
device
for
6


immediate
self-administration
of
a
measured
dose
of
epinephrine


7


by
a
person
at
risk
of
anaphylaxis.
8


a.
b.
“Medication”
means
a
drug
that
meets
the
definition
9


provided
in
section
126.2,
subsection
8
,
has
an
individual
10


prescription
label,
is
prescribed
by
a
physician
for
a
11


student,
and
pertains
to
the
student’s
asthma
or
other
airway
12


constricting
disease.
13


b.
c.
“Physician”
means
a
person
licensed
under
chapter
14


148
,
or
a
physician’s
assistant,
advanced
registered
nurse
15


practitioner,
or
other
person
licensed
or
registered
to
16


distribute
or
dispense
a
prescription
drug
or
device
in
the
17


course
of
professional
practice
in
this
state
in
accordance
18


with
section
147.107
,
or
a
person
licensed
by
another
state
19


in
a
health
field
in
which,
under
Iowa
law,
licensees
in
this
20


state
may
legally
prescribe
drugs.
21


c.


d.
“Self-administration”
means
a
student’s
discretionary
22


use
of
medication
prescribed
by
a
physician
for
the
student.
23


2.
The
board
of
directors
of
a
school
district
and
the
24


authorities
in
charge
of
an
accredited
nonpublic
school
shall
25


permit
the
self-administration
of
medication
by
a
student
26


with
asthma
or
other
airway
constricting
disease
or
the
use


27


of
an
epinephrine
auto-injector
by
a
student
if
the
following
28


conditions
are
met:
29


a.
The
student’s
parent
or
guardian
provides
to
the
school
30


written
authorization
for
the
self-administration
of
medication
31


or
for
the
use
of
an
epinephrine
auto-injector


.
32


b.
The
student’s
parent
or
guardian
provides
to
the
school
33


a
written
statement
from
the
student’s
physician
containing
the
34


following
information:
35


-1-


LSB
6101HV
(1)
85


je/rj


1/
4





















H.F.
2392


(1)
The
name
and
purpose
of
the
medication
or
epinephrine
1


auto-injector


.
2


(2)
The
prescribed
dosage.
3


(3)
The
times
at
which
or
the
special
circumstances
under
4


which
the
medication
or
epinephrine
auto-injector
is
to
be
5


administered.
6


c.
The
parent
or
guardian
and
the
school
meet
the
7


requirements
of
subsection
3
.
8


3.
The
school
district
or
accredited
nonpublic
school
9


shall
notify
the
parent
or
guardian
of
the
student,
in
10


writing,
that
the
school
district
or
accredited
nonpublic
11


school
and
its
employees
are
to
incur
no
liability,
except
12


for
gross
negligence,
as
a
result
of
any
injury
arising
from
13


self-administration
of
medication
or
use
of
an
epinephrine
14


auto-injector
by
the
student.
The
parent
or
guardian
of
the
15


student
shall
sign
a
statement
acknowledging
that
the
school
16


district
or
nonpublic
school
is
to
incur
no
liability,
except
17


for
gross
negligence,
as
a
result
of
self-administration
of
18


medication
or
use
of
an
epinephrine
auto-injector


by
the
19


student.
A
school
district
or
accredited
nonpublic
school
20


and
its
employees
acting
reasonably
and
in
good
faith
shall
21


incur
no
liability
for
any
improper
use
of
medication
or
an


22


epinephrine
auto-injector
as
defined
in
this
section
or
for
23


supervising,
monitoring,
or
interfering
with
a
student’s
24


self-administration
of
medication
or
use
of
an
epinephrine


25


auto-injector


as
defined
in
this
section
.
26


4.
The
permission
for
self-administration
of
medication
27


or
use
of
an
epinephrine
auto-injector
is
effective
for
the
28


school
year
for
which
it
is
granted
and
shall
be
renewed
each
29


subsequent
school
year
upon
fulfillment
of
the
requirements
30


of
this
section
.
However,
the
parent
or
guardian
shall
31


immediately
notify
the
school
of
any
changes
in
the
conditions
32


listed
under
subsection
2
.
33


5.
Provided
that
the
requirements
of
this
section
are
34


fulfilled,
a
student
with
asthma
or
other
airway
constricting
35


-2-


LSB
6101HV
(1)
85


je/rj


2/
4














H.F.
2392


disease
may
possess
and
use
the
student’s
medication
and
a
1


student
with
a
written
statement
from
a
physician
on
file


2


pursuant
to
subsection
2,
paragraph
“a”
may
use
an
epinephrine
3


auto-injector
while
in
school,
at
school-sponsored
activities,
4


under
the
supervision
of
school
personnel,
and
before
or
after
5


normal
school
activities,
such
as
while
in
before-school
or
6


after-school
care
on
school-operated
property.
If
the
student
7


misuses
this
privilege,
the
privilege
may
be
withdrawn.
A
8


school
district
or
nonpublic
school
shall
notify
a
student’s
9


parent
or
guardian
before
withdrawing
the
privilege
to
use
an
10


epinephrine
auto-injector.
11


6.
Information
provided
to
the
school
under
subsection
2
12


shall
be
kept
on
file
in
the
office
of
the
school
nurse
or,
in
13


the
absence
of
a
school
nurse,
the
school’s
administrator.
14


7.
The
Iowa
braille
and
sight
saving
school,
the
state
15


school
for
the
deaf,
and
the
institutions
under
the
control
of
16


the
department
of
human
services
as
provided
in
section
218.1
17


are
exempt
from
the
provisions
of
this
section
.
18


Sec.
2.
EPINEPHRINE
IN
SCHOOLS
——
STUDY
AND
REPORT.
The
19


department
of
public
health,
in
consultation
with
education
20


and
health
care
stakeholders,
shall
conduct
a
study
of
the
21


federal
School
Access
to
Emergency
Epinephrine
Act,
Pub.
L.
22


No.
113-48,
and
how
its
provisions
can
be
implemented
in
this
23


state,
including
but
not
limited
to
procedures
for
the
use
24


of
epinephrine
auto-injectors
in
schools,
training
of
school
25


personnel,
liability
protections,
reporting
requirements,
and
26


consent
requirements.
The
department
shall
submit
a
report
on
27


its
findings
and
recommendations
to
the
general
assembly
by
28


January
1,
2015.
29


EXPLANATION
30


The
inclusion
of
this
explanation
does
not
constitute
agreement
with
31


the
explanation’s
substance
by
the
members
of
the
general
assembly.
32


This
bill
adds
epinephrine
auto-injectors
to
Code
section
33


280.16,
which
permits
self-administration
of
medication
in
34


public
and
nonpublic
schools
by
students
with
asthma.
35


-3-


LSB
6101HV
(1)
85


je/rj


3/
4













H.F.
2392


The
bill
defines
“epinephrine
auto-injector”
as
a
medical
1


device
for
immediate
self-administration
of
a
measured
dose
of
2


epinephrine
by
a
person
at
risk
of
anaphylaxis.
3


The
bill
requires
school
districts
and
nonpublic
schools
4


to
allow
the
use
of
an
epinephrine
auto-injector
by
a
student
5


with
a
written
statement
from
a
physician
on
file
if
the
school
6


receives
written
authorization
and
certain
medical
information
7


from
the
student’s
parent
or
guardian.
8


The
bill
permits
a
student
with
a
written
statement
9


from
a
physician
on
file
to
possess
and
use
an
epinephrine
10


auto-injector
while
in
school,
at
school-sponsored
activities,
11


under
the
supervision
of
school
personnel,
and
before
or
after
12


normal
school
activities,
such
as
while
in
before-school
or
13


after-school
care
on
school-operated
property.
The
bill
14


requires
a
school
district
or
nonpublic
school
to
notify
a
15


student’s
parent
or
guardian
before
withdrawing
the
privilege
16


to
use
an
epinephrine
auto-injector.
17


The
bill
adds
epinephrine
auto-injectors
to
the
provisions
18


of
Code
section
280.16
granting
immunity
from
legal
liability
19


to
school
employees,
except
for
gross
negligence,
for
injuries
20


resulting
from
the
self-administration
of
medication.
Code
21


section
280.16
requires
a
student’s
parent
or
guardian
to
22


receive
notice
of
such
immunity.
23


The
bill
directs
the
department
of
public
health,
in
24


consultation
with
education
and
health
care
stakeholders,
to
25


conduct
a
study
of
the
federal
School
Access
to
Emergency
26


Epinephrine
Act,
and
how
its
provisions
can
be
implemented
in
27


this
state,
including
but
not
limited
to
procedures
for
the
use
28


of
epinephrine
auto-injectors
in
schools,
training
of
school
29


personnel,
liability
protections,
reporting
requirements,
and
30


consent
requirements.
The
department
must
submit
a
report
on
31


its
findings
and
recommendations
to
the
general
assembly
by
32


January
1,
2015.


33


-4-


LSB
6101HV
(1)
85


je/rj


4/
4

